Cambridge Healthtech Institute's (CHI) Third Annual Oligonucleotide & Peptide Therapeutics (OPT) Boston
In-Person Event
Mar 25 - 28, 2018
Cambridge, Massachusetts, USASpeakers
OVERVIEW
Cambridge Healthtech Institute's (CHI) Third Annual Oligonucleotide & Peptide Therapeutics (OPT) Boston is organized by Cambridge Healthtech Institute's (CHI) and will be held during Mar 25 - 28, 2018 at Boston Marriott Cambridge, Cambridge, Massachusetts, United States of America.
Conference Description :
This three-day event includes two main conferences covering topics within discovery, delivery, and early clinical studies, as well as a symposium focused on utilizing oligonucleotides and peptides to address rare diseases.
It has been estimated that only a fraction of known disease targets has been successfully met with therapeutic options. As our understanding of disease biology continues to outpace our ability to develop therapeutic agents, there is an urgent need to find new ways to unlock a greater portion of this “undruggable” target space. Oligonucleotide and peptide therapeutics have emerged as critical development platforms to meet this challenge, poised to produce highly specific, diverse and safe therapies while addressing a much wider range of targets than traditional small molecules or biologics.
• Oligonucleotide Discovery and Delivery will be heled during Mar 26 - 28, 2018.
• Peptide Discovery and Delivery will be heled during Mar 26 - 27, 2018.
• Symposium: Drug Discovery for Rare Diseases will be held on Mar 28, 2018.
Short Courses :
• SC1: Oligonucleotide Therapeutics: From Discovery to Manufacturing will be held on Mar 25, 2018.
• SC2: Overcoming Challenges with Peptide Delivery will be held on Mar 26, 2018.
• SC3: CRISPR-Based Gene Editing for Targeted Therapies will be held on Mar 27, 2018.
Additional details will be posted as soon as they are available.
Conference Description :
This three-day event includes two main conferences covering topics within discovery, delivery, and early clinical studies, as well as a symposium focused on utilizing oligonucleotides and peptides to address rare diseases.
It has been estimated that only a fraction of known disease targets has been successfully met with therapeutic options. As our understanding of disease biology continues to outpace our ability to develop therapeutic agents, there is an urgent need to find new ways to unlock a greater portion of this “undruggable” target space. Oligonucleotide and peptide therapeutics have emerged as critical development platforms to meet this challenge, poised to produce highly specific, diverse and safe therapies while addressing a much wider range of targets than traditional small molecules or biologics.
• Oligonucleotide Discovery and Delivery will be heled during Mar 26 - 28, 2018.
• Peptide Discovery and Delivery will be heled during Mar 26 - 27, 2018.
• Symposium: Drug Discovery for Rare Diseases will be held on Mar 28, 2018.
Short Courses :
• SC1: Oligonucleotide Therapeutics: From Discovery to Manufacturing will be held on Mar 25, 2018.
• SC2: Overcoming Challenges with Peptide Delivery will be held on Mar 26, 2018.
• SC3: CRISPR-Based Gene Editing for Targeted Therapies will be held on Mar 27, 2018.
Additional details will be posted as soon as they are available.
KEY DATES
25 Mar, 2018
Event Start Date
28 Mar, 2018
Event End Date
SPECIALITIES
Pharmacy and MedicineSUGGESTED HOTELS
CONFERENCE VENUE
Boston Marriott CambridgeRELATED CONFERENCES & LIVE WEBINARS
Quick Links